Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial
- Submitting institution
-
University of Plymouth
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 1390
- Type
- D - Journal article
- DOI
-
10.1016/S0140-6736(17)32365-6
- Title of journal
- The Lancet
- Article number
- -
- First page
- 2266
- Volume
- 390
- Issue
- 10109
- ISSN
- 0140-6736
- Open access status
- Not compliant
- Month of publication
- September
- Year of publication
- 2017
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
167
- Research group(s)
-
-
- Citation count
- 83
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- Syed Hussain contributed to data analysis, and interpretation AND Syed Hussain contributed to the drafting, review and approval of the manuscript.
- Non-English
- No
- English abstract
- -
